AIM: To investigate the clinical features and survival of patients treated for cholangiocarcinoma in our institution and to analyze the factors affecting their survival. METHODS: This retrospective cohort study assessed patients diagnosed with cholangiocarcinoma between January 1997 and December 2007 at the University Malaya Medical Centre in Malaysia. The clinical data and associated outcomes were collected using a structured proforma. RESULTS: Of the 69 patients diagnosed with cholangiocarcinoma, 38 (55%) were male; mean patient age was 61 years. Twelve patients (17%) had intrahepatic, 38 (55%) had perihilar and 19 (28%) had distal tumors. Only 12 patients underwent curative surgery, including seven R0 resections. Only one patient died within 30 d after surgery. The overall median survival was 4 mo, whereas the median survival of R0 resected patients was 16 mo. The overall 1-, 2- and 3-year cumulative survival rates were 67%, 17% and 17%, respectively. Survival rates were significantly associated with curative resection (P = 0.002), intrahepatic tumor (P = 0.003), negative margin status (P = 0.013), early tumor stage (P = 0.016), higher tumor differentiation (P = 0.032) and absence of jaundice (P = 0.038). Multivariate analysis showed that tumor location was a significant independent predictor of patient survival. CONCLUSION: Curative, margin-negative resection of early stage, well-differentiated intrahepatic tumors is associated with improved patient survival.
AIM: To investigate the clinical features and survival of patients treated for cholangiocarcinoma in our institution and to analyze the factors affecting their survival. METHODS: This retrospective cohort study assessed patients diagnosed with cholangiocarcinoma between January 1997 and December 2007 at the University Malaya Medical Centre in Malaysia. The clinical data and associated outcomes were collected using a structured proforma. RESULTS: Of the 69 patients diagnosed with cholangiocarcinoma, 38 (55%) were male; mean patient age was 61 years. Twelve patients (17%) had intrahepatic, 38 (55%) had perihilar and 19 (28%) had distal tumors. Only 12 patients underwent curative surgery, including seven R0 resections. Only one patient died within 30 d after surgery. The overall median survival was 4 mo, whereas the median survival of R0 resected patients was 16 mo. The overall 1-, 2- and 3-year cumulative survival rates were 67%, 17% and 17%, respectively. Survival rates were significantly associated with curative resection (P = 0.002), intrahepatic tumor (P = 0.003), negative margin status (P = 0.013), early tumor stage (P = 0.016), higher tumor differentiation (P = 0.032) and absence of jaundice (P = 0.038). Multivariate analysis showed that tumor location was a significant independent predictor of patient survival. CONCLUSION: Curative, margin-negative resection of early stage, well-differentiated intrahepatic tumors is associated with improved patient survival.
Entities:
Keywords:
Bile duct tumor; Cholangiocarcinoma; Malaysia; Surgery
Authors: F Donato; U Gelatti; A Tagger; M Favret; M L Ribero; F Callea; C Martelli; A Savio; P Trevisi; G Nardi Journal: Cancer Causes Control Date: 2001-12 Impact factor: 2.506
Authors: S A Khan; B R Davidson; R Goldin; S P Pereira; W M C Rosenberg; S D Taylor-Robinson; A V Thillainayagam; H C Thomas; M R Thursz; H Wasan Journal: Gut Date: 2002-11 Impact factor: 23.059
Authors: D M Parkin; P Srivatanakul; M Khlat; D Chenvidhya; P Chotiwan; S Insiripong; K A L'Abbé; C P Wild Journal: Int J Cancer Date: 1991-05-30 Impact factor: 7.396
Authors: Tzu-Hung Hsiao; Hung-I Harry Chen; Jo-Yang Lu; Pei-Ying Lin; Charles Keller; Sarah Comerford; Gail E Tomlinson; Yidong Chen Journal: Transl Cancer Res Date: 2013-02-01 Impact factor: 1.241
Authors: Olaf Neumann; Timothy C Burn; Michael Allgäuer; Markus Ball; Martina Kirchner; Thomas Albrecht; Anna-Lena Volckmar; Susanne Beck; Volker Endris; Hannah Goldschmid; Ulrich Lehmann; Huriye Seker-Cin; Sebastian Uhrig; Stephanie Roessler; Jan Budczies; Stefan Fröhling; Thomas Longerich; Alex H Wagner; Arndt Vogel; Peter Schirmacher; Albrecht Stenzinger; Daniel Kazdal Journal: Br J Cancer Date: 2022-07-23 Impact factor: 9.075
Authors: Elena V Poddubskaya; Madina P Baranova; Daria O Allina; Philipp Y Smirnov; Eugene A Albert; Alexey P Kirilchev; Alexey A Aleshin; Marina I Sekacheva; Maria V Suntsova Journal: Exp Hematol Oncol Date: 2018-09-06